Azaserine
From Wikidoc - Reading time: 1 min| File:Azaserine.png | |
| Identifiers | |
|---|---|
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C5H7N3O4 |
| Molar mass | 173.127 g/mol |
|
WikiDoc Resources for Azaserine |
|
Articles |
|---|
|
Most recent articles on Azaserine |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Azaserine at Clinical Trials.gov Clinical Trials on Azaserine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Azaserine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Azaserine Discussion groups on Azaserine Directions to Hospitals Treating Azaserine Risk calculators and risk factors for Azaserine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Azaserine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview[edit | edit source]
Azaserine is a carcinogen primarily used for researching pancreatic cancer in animal models. It is a glutamine analogue that inhibits glutamine phosphoribosyl amidotransferase, which is involved in the synthesis of purine nucleotides.
Original source: https://wikidoc.org/Azaserine
Status: article is cached
EncycloReader
is supported by the 
KSF